Clinical Trial Update: Cord Blood Nesfatin-1 and Irisin in the Intrauterine Growth Restricted Fetuses

View source ↗

Summary

A completed clinical trial evaluating cord blood levels of Nesfatin-1 and Irisin in fetuses with intrauterine growth restriction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Growth Restriction

Drugs mentioned

• Irisin (irisin)
• Nesfatin-1 (Nesfatin-1)

Snippet

Sponsor: Yuzuncu Yil University | Conditions: Nesfatin-1, Irisin | Status: COMPLETED